Professionnels de santé

Grand public

Transparency Committee Opinion

Date	19 March 2008
Pharmaceutical formulation	TARCEVA 25 mg, film-coated tablet (369 232-3) TARCEVA 100 mg, film-coated tablet (369 234-6) TARCEVA 150 mg, film-coated tablet (369 235-2) Pack of 30
ATC code	L01XE03
Active ingredient	erlotinib
Laboratory / Manufacturer	ROCHE
Reason for request	Inclusion on the list of medicines reimbursed by National Insurance and approved for hospital use in the extension of indication “Tarceva, in combination with gemcitabine, is indicated in the treatment of metastatic pancreatic cancer”.